INTERNATIONAL PATENT: UMOJA BIOPHARMA, INC., IASO BIOTHERAPEUTICS USA LIMITED FILES APPLICATION FOR "LENTIVIRAL DELIVERY OF ANTI-CD22 CHIMERIC ANTIGEN RECEPTORS"

GENEVA, Oct. 15 -- UMOJA BIOPHARMA, INC. (1150 Eastlake Avenue E., Suite 400Seattle, Massachusetts 98109), IASO BIOTHERAPEUTICS USA LIMITED (Lab# 209, 5941 Optical CtSan Jose, California 95138) filed a patent application (PCT/US2025/022794) for "LENTIVIRAL DELIVERY OF ANTI-CD22 CHIMERIC ANTIGEN RECEPTORS" on Apr 02, 2025. With publication no. WO/2025/212803, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NICOLAI, Christopher (c/o Umoja Biopharma, Inc.1150 Eastlake Avenue E., Suite 400Seattle, Washington 98109), QIN, Jim ...